DATE:             November 29, 2002

CONTACT:          John Hupp, Vice President
                  (952) 820-0022

RE:               Developed Technology Resource, Inc.

                              FOR IMMEDIATE RELEASE
                              ---------------------

         MINNEAPOLIS, MINNESOTA - Developed Technology Resource, Inc. (the
"Company") announced today that it has signed an Option Agreement on November
26, 2002 allowing for the acquisition of GelStat Corp. in exchange for shares of
the Company. GelStat Corp. is a development stage company involved in the
development and marketing of various non-prescription (OTC) consumer health
products. The option period is meant to allow the Company an opportunity to
evaluate the results of a now ongoing clinical trial.

         The Company expects to make a decision if it will exercise the option
within 30 days. If the Company elects to exercise the option and proceed with
the acquisition, GelStat's current shareholders will receive shares of DTR equal
to approximately 60% of the Company's then outstanding shares. In accordance
with the terms of the Option Agreement, the Company has loaned $300,000 to
GelStat for its use in completing the clinical trial and in preparing for the
planned national launch of its first product in March 2003.

         The common stock of the Company is traded on the OTC Bulletin Board
under the symbol DEVT.OB.

         This press release contains "forward-looking" statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements are based on the Company's current expectations and
involve known and unknown risks, uncertainties, or other factors which may cause
actual results, performance or achievements of the company to be materially
different from any future results, performance or achievements expressed or
implied by such forward-looking statements. Readers are cautioned not to place
undue reliance on those forward-looking statements, which speak only as of the
date hereof. The company undertakes no obligation to release publicly any
revisions to these forward-looking statements to reflect events or circumstances
after the date hereof or to reflect unanticipated events or developments.

                                     # # # #